{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:25:28Z","timestamp":1762503928377,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T00:00:00Z","timestamp":1495584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["tipsro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Technical Innovations &amp; Patient Support in Radiation Oncology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.tipsro.2017.08.002","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T18:08:41Z","timestamp":1504721321000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Treatment of symptomatic splenomegaly with low doses of radiotherapy: Retrospective analysis and review of the literature"],"prefix":"10.1016","volume":"3-4","author":[{"given":"Carolina","family":"de la Pinta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Fern\u00e1ndez Lizarbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Montero Luis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Dom\u00ednguez Rull\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonsoles","family":"Sancho Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tipsro.2017.08.002_b0005","unstructured":"Harrison\u2019s principles of internal medicine, 19th ed. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors."},{"issue":"2","key":"10.1016\/j.tipsro.2017.08.002_b0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/01.COC.0000017799.59129.7D","article-title":"Palliative irradiation of the spleen","volume":"26","author":"Mc Farland","year":"2003","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.tipsro.2017.08.002_b0015","first-page":"231","article-title":"Splenic irradiation: apropos of 8 cases. Clinical indications and literature review","volume":"24","author":"Iba\u00f1ez-Villoslada","year":"2007","journal-title":"An Med Int"},{"issue":"9","key":"10.1016\/j.tipsro.2017.08.002_b0020","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1748-717X-9-86","article-title":"Low-dose splenic irradiation in symptomatic congestive splenomegaly: report of five cases with literature data","volume":"27","author":"Bruns","year":"2014","journal-title":"Radiat Oncol"},{"issue":"7","key":"10.1016\/j.tipsro.2017.08.002_b0025","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.43.540","article-title":"Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment","volume":"43","author":"Dingli","year":"2004","journal-title":"Int Med"},{"issue":"22","key":"10.1016\/j.tipsro.2017.08.002_b0030","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2009-02-195974","article-title":"How I treat symptomatic splenomegaly in patients with myelofibrosis","volume":"113","author":"Mesa","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tipsro.2017.08.002_b0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0167-8140(00)00316-9","article-title":"Clinical indications and biological mechanisms of splenic irradiation in chronic leukaemias and myeloproliferative disorders","volume":"58","author":"Weinmann","year":"2001","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.tipsro.2017.08.002_b0040","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cld.2014.07.006","article-title":"Transjugular intrahepatic portosystemic shunt","volume":"18","author":"Patidar","year":"2014","journal-title":"Vlin Liver Dis"},{"issue":"45","key":"10.1016\/j.tipsro.2017.08.002_b0045","doi-asserted-by":"crossref","first-page":"16996","DOI":"10.3748\/wjg.v20.i45.16996","article-title":"Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications","volume":"20","author":"Siramolpiwat","year":"2014","journal-title":"World J Gastroen"},{"key":"10.1016\/j.tipsro.2017.08.002_b0050","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/rg.322115135","article-title":"Image-guided percutaneous splenic interventions","volume":"32","author":"Singh","year":"2012","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.tipsro.2017.08.002_b0055","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/liv.12702","article-title":"Big spleens and hypersplenism: fix it or forget it?","volume":"35","author":"Boyer","year":"2015","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.tipsro.2017.08.002_b0060","first-page":"19642","article-title":"Percutaneous transhepatic embolization of gastroesophageal varices combined with parcial splenic embolization for the treatment of variceal bleeding and hypersplenism","volume":"8","author":"Gong","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.tipsro.2017.08.002_b0065","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1148\/rg.25si055504","article-title":"Splenic arterial interventions: anatomy, indications, technical considerations, and potential complications","author":"Madoff","year":"2005","journal-title":"Radiographics"},{"key":"10.1016\/j.tipsro.2017.08.002_b0070","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1182\/blood.V95.7.2226","article-title":"Splenectomy in myelofibrosis with myeloid metaplasia: a single institution experience with 223 patients","volume":"95","author":"Tefferi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tipsro.2017.08.002_b0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clon.2004.12.003","article-title":"An audit of the indications for and techniques of palliative splenic radiotherapy in the UK","volume":"17","author":"Jyothirmayiu","year":"2005","journal-title":"Clin Oncol"},{"issue":"4","key":"10.1016\/j.tipsro.2017.08.002_b0080","first-page":"1134","article-title":"Splenic irradiation as palliative treatment for symptomatic splenomegaly due to secondary myelofibrosis: a multiinstitucional experience","volume":"20","author":"Pistevou-Gombaki","year":"2015","journal-title":"JBUON"},{"key":"10.1016\/j.tipsro.2017.08.002_b0085","first-page":"281","article-title":"Case of splenomedullary leukaemia successfully treated by the use of roentgen ray","volume":"63","author":"Senn","year":"1903","journal-title":"Med Rec"},{"key":"10.1016\/j.tipsro.2017.08.002_b0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0145-2126(00)00018-7","article-title":"Safety and efficacy of splenic irradiation in the treatment of patients with idiopathic myelofibrosis: a report on 15 patients","volume":"24","author":"Bouabdallah","year":"2000","journal-title":"Leuk Res"},{"key":"10.1016\/j.tipsro.2017.08.002_b0115","article-title":"Clinical application of partial splenic embolization","volume":"2014","author":"Yong-Song","year":"2014","journal-title":"Sci World J"},{"key":"10.1016\/j.tipsro.2017.08.002_b0125","doi-asserted-by":"crossref","first-page":"20140374","DOI":"10.1259\/bjr.20140374","article-title":"High-intensity focused ultrasound ablation: an effective and safe treatment for secondary hypersplenism","volume":"87","author":"Zhy","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.tipsro.2017.08.002_b0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1054\/blre.1999.0110","article-title":"Splenic irradiation in myelofibrosis with myeloid metaplasia: a review","volume":"13","author":"Elliott","year":"1999","journal-title":"Blood Rev"},{"key":"10.1016\/j.tipsro.2017.08.002_b0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/104990919601300613","article-title":"Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders","volume":"13","author":"Paulino","year":"1996","journal-title":"Am J Hosp Plliat Care"},{"key":"10.1016\/j.tipsro.2017.08.002_b0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0360-3016(89)90035-7","article-title":"A study of splenic irradiation in chronic lymphocytic leukaemia","volume":"16","author":"Guiney","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.tipsro.2017.08.002_b0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s002770000265","article-title":"Clinical and immunological evaluation of primary splenic irradiation in chronic lymphocytic leukaemia: a study of 24 cases","volume":"80","author":"Van Mook","year":"2001","journal-title":"Ann Haematol"},{"key":"10.1016\/j.tipsro.2017.08.002_b0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1046\/j.1365-2141.1998.00998.x","article-title":"Splenic irradiation for symptomatic splenomegaly associated with myelofibrosis with myeloid metaplasia","volume":"103","author":"Elliott","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tipsro.2017.08.002_b0155","first-page":"87","article-title":"Splenic irradiation in the treatment of idiopathic myelofibrosis. Retrospective study of 14 cases","volume":"76","author":"Sciascia","year":"1988","journal-title":"Radiol Med"},{"key":"10.1016\/j.tipsro.2017.08.002_b0160","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/jjco\/28.4.267","article-title":"Splenic irradiation for prolymphocytic leukemia: is it preferable as initial treatment or not?","volume":"28","author":"Yamamoto","year":"1998","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.tipsro.2017.08.002_b0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/blood.V53.3.412.412","article-title":"Leukemic reticuloendotheliosis (hairy cell leukemia)","volume":"53","author":"Bouroncle","year":"1979","journal-title":"Blood"},{"key":"10.1016\/j.tipsro.2017.08.002_b0170","article-title":"The mechanism of action of splenic irradiation in chronic myelogenous leukemia","volume":"96","author":"Galbraith","year":"1967","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.tipsro.2017.08.002_b0175","first-page":"860","article-title":"Splenic irradiation for the treatment of hypersplenism from congestive splenomegaly","volume":"84","author":"Kenawi","year":"1997","journal-title":"Br J Surg"},{"key":"10.1016\/j.tipsro.2017.08.002_b0180","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5144\/0256-4947.2004.198","article-title":"Radiotherapy for hypersplenism from congestive splenomegaly","volume":"24","author":"Liu","year":"2004","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.tipsro.2017.08.002_b0185","doi-asserted-by":"crossref","DOI":"10.1007\/s00066-011-2252-4","article-title":"Radiotherapy of splenomegaly. A palliative treatment option for a benign phenomenon in malignant diseases","author":"Kriz","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.tipsro.2017.08.002_b0190","first-page":"29","article-title":"Splenic irradiation in hematologic malignances and other hematologic disorders-single institution experience","volume":"50","author":"Soldic","year":"2011","journal-title":"Acta Clin Croat"},{"key":"10.1016\/j.tipsro.2017.08.002_b0195","first-page":"31","article-title":"Palliative spleen irradiation: can we standardize its technique?","volume":"20","author":"Namzy","year":"2008","journal-title":"J Egypt Nat Cancert Inst"},{"key":"10.1016\/j.tipsro.2017.08.002_b0200","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2011.36","article-title":"How to manage\u2026Ellipsis How I treat splenomegaly in myelofibrosis","author":"Cervantes","year":"2011","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1016\/j.tipsro.2017.08.002_b0205","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/10428194.2011.614708","article-title":"Low dose palliative radiotherapy for splenomegaly in hematologic disorders","volume":"53","author":"Lavrenkov","year":"2012","journal-title":"Leukemia Lymphoma"},{"issue":"11\u201312","key":"10.1016\/j.tipsro.2017.08.002_b0210","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0360-3016(77)90113-4","article-title":"Irradiation for control of hypersplenism and painful splenomegaly in myeloid metaplasia","volume":"2","author":"Greenberger","year":"1977","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.tipsro.2017.08.002_b0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ajh.2830190210","article-title":"Spleen irradiation in chronic lymphocytic leukemia (CLL): palliation in patients unfit for splenectomy","volume":"19","author":"Aabo","year":"1985","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.tipsro.2017.08.002_b0220","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/1097-0142(19860915)58:6<1204::AID-CNCR2820580605>3.0.CO;2-G","article-title":"Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea","volume":"58","author":"Wagner","year":"1986","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.tipsro.2017.08.002_b0230","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1440-1673.2008.01958.x","article-title":"Low-dose palliative splenic irradiation in haematolymphoid malignancy","volume":"52","author":"Shrimali","year":"2008","journal-title":"J Med Imag Radiat Oncol"}],"container-title":["Technical Innovations &amp; Patient Support in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632417300136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405632417300136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:15:16Z","timestamp":1762503316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405632417300136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":40,"alternative-id":["S2405632417300136"],"URL":"https:\/\/doi.org\/10.1016\/j.tipsro.2017.08.002","relation":{},"ISSN":["2405-6324"],"issn-type":[{"type":"print","value":"2405-6324"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of symptomatic splenomegaly with low doses of radiotherapy: Retrospective analysis and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Technical Innovations & Patient Support in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tipsro.2017.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ireland Ltd on behalf of European Society for Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}]}}